Impact of passing through rebates at the POS for diabetes medicines
Life Sciences Impact of passing through rebates at the POS for diabetes medicines 11 May 2018 Wayne Su Diabetes imposes a significant economic...
As a recognized expert in health economics and pricing, Wayne has advised the very top of international governments, such as the White House, Congressional Budget Office, US-China Health Summit, US state legislature, top US think tanks, China's Ministry of Health, and the World Health Organization. His work was featured in major global news outlets such as Wall Street Journal, New York Times, USA Today, BioPharm Insight, and international conferences.
Wayne has a track record of success on pricing, reimbursement (including HTA submission), health economics modeling, market access, and pharmaceutical business strategies. His clientele ranges from health care start-ups, Fortune 100 pharmaceutical companies, to international governments and influential advocacy groups. His work has led to more than $10 billion USD in global sales. Wayne has a Master’s degree in Operations Research and is bilingual in English and Chinese.